BRCA1 regulates caveolin-1 expression and inhibits cell invasiveness

Biochemical and Biophysical Research Communications

Volumn 370, Issue 2, 2008, Pages 201-206

  Wang, Yang ^a   Yu, Jing ^a   Zhan, Qimin ^a  

^a Hospital of Cancer   (China)

Author keywords

BRCA1; Caveolin 1; Gene expression; Invasiveness; Translocation

Indexed keywords

BRCA1 PROTEIN; CAVEOLIN 1;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL INVASION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSACTIVATION;

ANIMALS; BRCA1 PROTEIN; BREAST NEOPLASMS; CAVEOLIN 1; CELL ADHESION; CELL MEMBRANE; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HELA CELLS; HUMANS; LUCIFERASES; MICE; NEOPLASM INVASIVENESS; PROMOTER REGIONS (GENETICS); PROTEIN TRANSPORT; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

MAMMALIA;

EID: 42449153673     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.031     Document Type: Article

References (22)

1. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
2. Deng C.X. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 34 (2006) 1416-1426
3. Koleske A.J., Baltimore D., and Lisanti M.P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92 (1995) 1381-1385
4. Lee S.W., Reimer C.L., Oh P., Campbell D.B., and Schnitzer J.E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16 (1998) 1391-1397
5. Xu X., Weaver Z., Linke S.P., Li C., Gotay J., Wang X.W., Harris C.C., Ried T., and Deng C.X. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3 (1999) 389-395
6. Shao S., Wang Y., Jin S., Song Y., Wang X., Fan W., Zhao Z., Fu M., Tong T., Dong L., Fan F., Xu N., and Zhan Q. Gadd45a interacts with aurora-A and inhibits its kinase activity. J. Biol. Chem. 281 (2006) 28943-28950
7. Yu J., Qian H., Li Y., Wang Y., Zhang X., Liang X., Fu M., and Lin C. Arsenic trioxide (As(2)O(3)) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. Gynecol. Oncol. 106 (2007) 400-406
8. Wang Y., and Zhan Q. Cell cycle-dependent expression of centrosomal ninein-like protein in human cells is regulated by the anaphase-promoting complex. J. Biol. Chem. 282 (2007) 17712-17719
9. van den Heuvel A.P., Schulze A., and Burgering B.M. Direct control of caveolin-1 expression by FOXO transcription factors. Biochem. J. 385 (2005) 795-802
10. Somasundaram K., Zhang H., Zeng Y.X., Houvras Y., Peng Y., Zhang H., Wu G.S., Licht J.D., Weber B.L., and El-Deiry W.S. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389 (1997) 187-190
11. Ganesan S., Silver D.P., Greenberg R.A., Avni D., Drapkin R., Miron A., Mok S.C., Randrianarison V., Brodie S., Salstrom J., Rasmussen T.P., Klimke A., Marrese C., Marahrens Y., Deng C.X., Feunteun J., and Livingston D.M. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 111 (2002) 393-405
12. Glait C., Ravid D., Lee S.W., Liscovitch M., and Werner H. Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells. FEBS Lett. 580 (2006) 5268-5274
13. Couch F.J., DeShano M.L., Blackwood M.A., Calzone K., Stopfer J., Campeau L., Ganguly A., Rebbeck T., and Weber B.L. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336 (1997) 1409-1415
14. Furuta S., Jiang X., Gu B., Cheng E., Chen P.L., and Lee W.H. Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells. Proc. Natl. Acad. Sci. USA 102 (2005) 9176-9181
15. Carvalho M.A., Billack B., Chan E., Worley T., Cayanan C., and Monteiro A.N. Mutations in the BRCT domain confer temperature sensitivity to BRCA1 in transcription activation. Cancer Biol. Ther. 1 (2002) 502-508
16. Krum S.A., Miranda G.A., Lin C., and Lane T.F. BRCA1 associates with processive RNA polymerase II. J. Biol. Chem. 278 (2003) 52012-52020
17. Schnitzer J.E., Oh P., and McIntosh D.P. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 274 (1996) 239-242
18. McIntosh D.P., Tan X.Y., Oh P., and Schnitzer J.E. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc. Natl. Acad. Sci. USA 99 (2002) 1996-2001
19. Liu P., Rudick M., and Anderson R.G. Multiple functions of caveolin-1. J. Biol. Chem. 277 (2002) 41295-41298
20. Fan W., Jin S., Tong T., Zhao H., Fan F., Antinore M.J., Rajasekaran B., Wu M., and Zhan Q. BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. J. Biol. Chem. 277 (2002) 8061-8067
21. Williams T.M., and Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288 (2005) C494-C506
22. Lu Z., Ghosh S., Wang Z., and Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4 (2003) 499-515